Latest Precigen News & Updates
See the latest news and media coverage for Precigen. We track all announcements, press releases, and industry mentions in real time, all in one place.
Commercial-stage biopharmaceutical company
precigen.com- Headquarters
- Germantown, United States
- Founded year
- 2020
- Company type
- Public company
- Number of employees
- 150–200
Latest news about Precigen
Company announcements
-
Precigen announces permanent J-code for HPV immunotherapy
Joe Merkert explains its significance for RRP patients' access and billing. Milestone enhances patient reach.
-
Precigen reports full year 2025 financial results
PAPZIMEOS generated $3.4M revenue; cash totals $100.4M; commercialization advances with J-code and EMA review.
-
Precigen's CEO Helen Sabzevari features in CNBC's 2026 Changemakers
The post congratulates her and other women transforming business. Watch the Squawk Box segment.
-
Precigen congratulates CEO Helen Sabzevari on CNBC Changemaker recognition
This honors her leadership in innovative therapies and Precigen's first FDA approval ahead of industry benchmarks.
Media coverage
-
Precigen Insider Trading Activity | NASDAQ:PGEN | Benzinga
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions...
-
Precigen sees Q1 revenue exceeding $18M, consensus $20.8M
This substantial advancement constitutes a pivotal milestone for all stakeholders impacted by RRP." As a result of the interest in PAPZIMEOS, Sabzevari said the company...
-
(PGEN) Precigen Expects Q1 Revenue to Exceed $18M, vs. FactSet Est of $20.8M | MarketScreener
The Company operates through two segments: Biopharmaceuticals and Exemplar. Biopharmaceuticals segment is primarily comprised of the Company's legal entities of Precigen and ActoBio, as well...
-
Precigen (PGEN) Sees Strong Demand for Papzimeos Immunotherapy
Key Takeaways: Precigen's immunotherapy, Papzimeos, has seen a significant increase in adoption since its launch in August 2025. The assignment of J-code...
Track Precigen and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI
Mips
Vexlum
Asker Healthcare Group
FAKRO